Short answer
Omada Health, Inc. (OMDA) filed its Q2 2026 10-Q quarterly report on Aug 7, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $88M (down 24.5% year over year) with net income of $5M.
Q2 2026 key financials · XBRL
- Revenue
- $88M
- −24.5% YoY · +12.5% QoQ
- Net income
- $5M
- +135.9% YoY · +278.2% QoQ
- Operating margin
- 4.0%
- Gross margin
- 72.6%
- EPS (diluted)
- $0.09
- +109.2% YoY · +280.0% QoQ
Source: XBRL data from the Omada Health, Inc. (OMDA) Q2 2026 10-Q on SEC EDGAR. USD.
Omada Health, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $87.835M, up 43% YoY from $61.371M; services $80.692M, hardware $7.143M
- Gross margin 73% vs 65% YoY; operating margin 4% vs negative 7%
- Hardware strongest growth, up 62% to $7.143M; services up 42% to $80.692M
- Net income $5.294M vs $5.311M loss; operating income $3.549M vs $4.344M loss
- Headwinds: higher device costs, tariffs, shipping expenses, and lower average service fees per member
Risk Factors
- Material weakness in internal control over financial reporting, risking inaccurate or delayed reporting and reduced investor confidence
- Healthcare regulatory changes, including Medicare Physician Fee Schedule modifications and PREVENT Diabetes Act implementation, creating uncertain coverage opportunities
- AI-native healthcare competitors and general-purpose AI tools increasing pricing pressure and member substitution risk
- Customer and channel-partner concentration limiting revenue diversification and increasing enrollment-related volatility
- Net income $5.3 million in Q2 2026 versus $(5.3) million loss in Q2 2025, but accumulated deficit remained $454.4 million
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Omada Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.